| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.1996.03530380035028 |
| P698 | PubMed publication ID | 8601928 |
| P2093 | author name string | G M Shaw | |
| D Schaffer | |||
| E M Velie | |||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| human pregnancy | Q11995 | ||
| P304 | page(s) | 1093-1096 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Risk of neural tube defect-affected pregnancies among obese women | |
| P478 | volume | 275 |
| Q35051429 | A 10 bp deletion polymorphism and 2 new variations in the GLUT1 gene associated with meningomyelocele |
| Q56792401 | A description of spina bifida cases and co-occurring malformations, 1976-2011 |
| Q34566069 | A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folate |
| Q37165888 | Acephalous lamb from an in vitro-produced sheep embryo |
| Q36319750 | Advances in understanding the molecular causes of diabetes-induced birth defects. |
| Q36468000 | Association between weight gain during pregnancy and neural tube defects and gastroschisis in offspring |
| Q36422334 | Association of copper-zinc superoxide dismutase (SOD1) and manganese superoxide dismutase (SOD2) genes with nonsyndromic myelomeningocele |
| Q35772757 | Association of facilitated glucose transporter 2 gene variants with the myelomeningocele phenotype |
| Q37306162 | Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in the Danish National Birth Cohort |
| Q45975228 | Biparietal diameter at 11-13 weeks' gestation in fetuses with open spina bifida. |
| Q44685701 | Body mass index and birth defects: Texas, 2005-2008. |
| Q40454699 | Body mass index and serum folate in childbearing age women. |
| Q35940242 | Clinical utility of folate-containing oral contraceptives |
| Q55642800 | Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population. |
| Q36581497 | Current perspectives on the genetic causes of neural tube defects |
| Q37351323 | Diabetes and apoptosis: neural crest cells and neural tube. |
| Q36606588 | Diabetes and obesity-related genes and the risk of neural tube defects in the national birth defects prevention study |
| Q44311996 | Diet quality and risk of neural tube defects |
| Q60213728 | Do infants with major congenital anomalies have an excess of macrosomia? |
| Q55080413 | Does arsenic increase the risk of neural tube defects among a highly exposed population? A new case-control study in Bangladesh. |
| Q42838770 | Does global hypomethylation contribute to susceptibility to neural tube defects? |
| Q27010571 | Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring? |
| Q38550879 | Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate |
| Q38549821 | Drug and environmental factors associated with adverse pregnancy outcomes. Part II: Improvement with folic acid |
| Q36263407 | Dyslipidemia in pregnancy may contribute to increased risk of neural tube defects -a pilot study in north Indian population |
| Q51632845 | Epidemiology of congenital anomalies in a population-based birth registry in Taiwan, 2002. |
| Q55030249 | Fat-Bone Interactions in Adults With Spina Bifida. |
| Q34018860 | Fetal anomalies in obese women: the contribution of diabetes |
| Q35131956 | Fetal serum folate concentrations and placental folate transport in obese women. |
| Q40799758 | Findings from the National Birth Defects Prevention Study: Interpretation and translation for the clinician. |
| Q37246148 | Gene-nutrient interactions: importance of folic acid and vitamin B12 during early embryogenesis |
| Q36992673 | Genes in glucose metabolism and association with spina bifida |
| Q40528191 | Genetic association of the glycine cleavage system genes and myelomeningocele. |
| Q38135224 | Genetic studies of myelomeningocele |
| Q34111801 | Genetic variations in the GLUT3 gene associated with myelomeningocele |
| Q38385449 | Heme oxygenase-1 promoter polymorphisms and risk of spina bifida |
| Q34213357 | High-density single nucleotide polymorphism screen in a large multiplex neural tube defect family refines linkage to loci at 7p21.1-pter and 2q33.1-q35. |
| Q57910461 | How does maternal obesity affect the routine fetal anatomic ultrasound? |
| Q37339099 | Human teratogens: current controversies |
| Q40480654 | Impact of Periconceptional Use of Nitrosatable Drugs on the Risk of Neural Tube Defects. |
| Q43620468 | In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes |
| Q37207130 | Influence of maternal body mass index on gestational weight gain and birth weight: A comparison of parity |
| Q38505367 | Integrating genetic and toxicogenomic information for determining underlying susceptibility to developmental disorders |
| Q40204079 | Interaction between the SLC19A1 gene and maternal first trimester fever on offspring neural tube defects |
| Q37695522 | Intersection of complex genetic traits affecting maternal metabolism, fetal metabolism, and neural tube defect risk: looking for needles in multiple haystacks |
| Q34021962 | Maternal body mass index and congenital anomaly risk: a cohort study. |
| Q36327010 | Maternal dietary glycaemic intake during pregnancy and the risk of birth defects |
| Q33741421 | Maternal dietary glycemic intake and the risk of neural tube defects |
| Q44997692 | Maternal obesity and infant heart defects |
| Q28345665 | Maternal obesity and risk of neural tube defects |
| Q37172224 | Maternal obesity and the risk of infant death in the United States |
| Q34327550 | Maternal obesity, folate intake, and neural tube defects in offspring |
| Q44132334 | Maternal periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case-control study |
| Q40902751 | Maternal serum screening for fetal genetic disorders |
| Q35384441 | Maternal-fetal metabolic gene-gene interactions and risk of neural tube defects |
| Q36739664 | Myelomeningocele: neglected aspects |
| Q30367650 | Obesity and pregnancy. |
| Q37734754 | Obesity and the risk and detection of fetal malformations |
| Q60483074 | Obesity in children |
| Q73937918 | Obesity in women of childbearing age: risks, prevention, and treatment |
| Q61843420 | Overview on neural tube defects: From development to physical characteristics |
| Q33990133 | Overweight and Obesity before, during and after Pregnancy: Part 2: Evidence-based Risk Factors and Interventions |
| Q34079524 | Overweight and obesity knowledge prior to pregnancy: a survey study. |
| Q44435409 | Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects |
| Q35163935 | Periconceptional multivitamin use and risk of preterm or small-for-gestational-age births in the Danish National Birth Cohort |
| Q34091191 | Periconceptional nutrient intakes and risks of neural tube defects in California |
| Q46445919 | Physical activity and risk of neural tube defects |
| Q41578076 | Poor sleep during the periconceptional period increases risk for neural tube defects in offspring |
| Q54976624 | Population-based case-control study of the association between weather-related extreme heat events and neural tube defects. |
| Q34155975 | Position of the American Dietetic Association: nutrition and lifestyle for a healthy pregnancy outcome |
| Q35249941 | Preimplantation exposure of mouse embryos to palmitic acid results in fetal growth restriction followed by catch-up growth in the offspring |
| Q54975843 | Prepregnancy Body Mass Index and Congenital Heart Defects among Offspring: A Population-based Study |
| Q77537959 | Prepregnancy body mass index and risk of multiple congenital anomalies |
| Q37802813 | Prepregnancy obesity: a complex risk factor for selected birth defects |
| Q33818319 | Prepregnant obesity and risks of selected birth defects in offspring |
| Q54257628 | Prevalence of obesity among Bangladeshi pregnant women at their first trimester of pregnancy. |
| Q36669761 | Recruitment and retention of pregnant women for a behavioral intervention: lessons from the maternal adiposity, metabolism, and stress (MAMAS) study |
| Q34806367 | Relationships between pregnancy outcomes, biochemical markers and pre-pregnancy body mass index |
| Q33918341 | Risk factors of neural tube defects in northern iran. |
| Q40795288 | Serum and red-blood-cell folate demonstrate differential associations with BMI in pregnant women |
| Q56168692 | Spina bifida |
| Q41731742 | Spina bifida phenotypes in infants or fetuses of obese mothers |
| Q34031426 | Spinal dysraphism: A challenge continued to be faced by neurosurgeons in developing countries |
| Q35121247 | Strenuous Work, Nutrition and Adverse Pregnancy Outcomes: A Brief Review |
| Q24245694 | Surgery for morbid obesity |
| Q37133573 | Syndromes, disorders and maternal risk factors associated with neural tube defects (I). |
| Q33304729 | Teratogenicity associated with pre-existing and gestational diabetes |
| Q64896865 | The Effects of Overweight and Obesity on Assisted Reproduction Technology Outcomes. |
| Q35220402 | The application of a chemical determination of N-homocysteinylation levels in developing mouse embryos: implication for folate responsive birth defects. |
| Q36914843 | The continuing challenge of understanding, preventing, and treating neural tube defects. |
| Q38209357 | The effect of maternal body mass index on fetal growth: use of individualized growth assessment and two-level linear modeling |
| Q44550921 | The etiology of neural tube defects: the role of folic acid |
| Q37707826 | The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida |
| Q80433370 | The impact of maternal obesity on midtrimester sonographic visualization of fetal cardiac and craniospinal structures |
| Q36797174 | The impact of maternal obesity on mother and neonatal health: study in a tertiary hospital of Astana, Kazakhstan |
| Q41820463 | The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts |
| Q37349983 | Understanding diabetic teratogenesis: where are we now and where are we going? |
| Q36139260 | Use of antipsychotics in the management of schizophrenia during pregnancy |
| Q43671845 | Weekly administration of folic acid and epidemiology of neural tube defects |
| Q36057792 | Working towards a risk prediction model for neural tube defects |
Search more.